Yi Larson

2019 - Turning Point Therapeutics

In 2019, Yi Larson earned a total compensation of $12.6M as Former Executive Vice President and Chief Financial Officer at Turning Point Therapeutics.

Compensation breakdown

Bonus$360,757
Non-Equity Incentive Plan$283,500
Option Awards$11,715,012
Salary$158,523
Other$61,633
Total$12,579,425

Larson received $11.7M in option awards, accounting for 93% of the total pay in 2019.

Larson also received $360.8K in bonus, $283.5K in non-equity incentive plan, $158.5K in salary and $61.6K in other compensation.

Rankings

In 2019, Yi Larson's compensation ranked 486th out of 13,971 executives tracked by ExecPay. In other words, Larson earned more than 96.5% of executives.

ClassificationRankingPercentile
All
486
out of 13,971
97th
Division
Manufacturing
180
out of 5,701
97th
Major group
Chemicals And Allied Products
47
out of 2,200
98th
Industry group
Drugs
39
out of 1,886
98th
Industry
Pharmaceutical Preparations
32
out of 1,398
98th
Source: SEC filing on April 29, 2022.

Larson's colleagues

We found three more compensation records of executives who worked with Yi Larson at Turning Point Therapeutics in 2019.

2019

Mohammad Hirmand

Turning Point Therapeutics

Chief Medical Officer

2019

Athena Countouriotis

Turning Point Therapeutics

Chief Executive Officer

2019

Annette North

Turning Point Therapeutics

General Counsel

News

In-depth

You may also like